PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
Not Applicable
Completed
- Conditions
- Chronic Myeloid Leukemia (chronic phase)
- Registration Number
- JPRN-UMIN000001900
- Lead Sponsor
- Inter-Michinoku Dasatinib Study(IMIDAS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
double cancer pregnancy etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MMR rate
- Secondary Outcome Measures
Name Time Method